Understanding how a protein interacts with cholesterol in the eye lens to cause cataracts
Interaction of alpha-crystallin with cholesterol bilayer domains in cataract formation
This study is looking at how a protein called alpha-crystallin interacts with cholesterol in the eye lens, which could help us understand how cataracts form as we get older, with the hope of finding ways to prevent or even reverse them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boise State University NIH-funded |
| Lab location | 1 site (Boise, United States) |
| Project ID | NIH-10862407 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called alpha-crystallin in the development of cataracts, focusing on how it binds to cholesterol in the membranes of eye lens cells. The study aims to uncover the mechanisms behind this binding process, which is crucial for maintaining lens transparency. By using advanced techniques like atomic force microscopy and spectroscopy, researchers will explore how changes in protein behavior contribute to cataract formation, especially as people age. The ultimate goal is to identify ways to prevent or reverse cataract development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of developing cataracts, particularly older adults.
Not a fit: Patients with cataracts caused by factors unrelated to protein interactions or cholesterol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating cataracts, potentially improving vision for millions of patients.
How similar studies have performed: Previous research has shown promising results in understanding protein interactions in cataract formation, suggesting that this approach could yield valuable insights.
Where this research is happening
Boise, United States
- Boise State University — Boise, United States (Active)
Researchers
- Principal investigator: Mainali, Laxman — Boise State University
- Study coordinator: Mainali, Laxman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.